Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Recruiting now
Conditions studied: Breast Cancer, Hereditary Breast and Ovarian Cancer
In brief
PROGECT is a registry for patients with Triple Negative breast cancer (TNBC) or patients who have an identified germline mutations (such as a mutation on the BRCA1 or BRCA2 genes).
Key facts
- Study ID
- NCT02302742
- Run by
- University of Kansas Medical Center
- People needed
- 1500
- Starts
- 2011-03-22
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2025-10-06
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
Where it is running
- Hays Medical Center Dreiling-Schmidt Cancer Institute — Hays, Kansas, United States (enrolling)
- KCCC West — Kansas City, Kansas, United States (enrolling)
- KCCC Overland Park — Overland Park, Kansas, United States (enrolling)
- Overland Park Regional Medical Center — Overland Park, Kansas, United States (enrolling)
- Salina Regional Health Center - Tammy Walker Cancer Center — Salina, Kansas, United States (enrolling)
- The University of Kansas Cancer Center — Westwood, Kansas, United States (enrolling)
- Universtiy Health — Kansas City, Missouri, United States (enrolling)
- KCCC South — Kansas City, Missouri, United States (enrolling)
- Research Medical Center — Kansas City, Missouri, United States (enrolling)
- KCCC - North — Kansas City, Missouri, United States (enrolling)
- KCCC Lee's Summit — Lee's Summit, Missouri, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.